drugset / Trial / NCT05105698
Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mg
RandomizedCrossoverOpen-labelTreatment
Summary
A Randomized, Open-label, Single-dose, Two-way Crossover Study to Investigate Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mg Fixed Dose Combination Film-coated Tablet under Fed and Fasting Conditions in Healthy Volunteers
Timeline
- Start
- 2022-01-01
- Primary completion
- 2022-02-28
- Completion
- 2022-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Gemigliptin | Small molecule | 50 mg | Oral |
Indications
No indication recorded.